Nov 3rd, 2010 | By Keelan Balderson
It’s not enough to have a full blown media campaign, the complicity of schools or to plaster the cancerous death of celeb Jade Goody on every newspaper; girls in Britain are now being bribed with £45 worth of high street shopping vouchers in exchange for rolling up their sleeve and taking the HPV vaccination, that allegedly prevents cervical cancer.
As reported by Mail Online:
The shopping voucher scheme is being run by Birmingham East and North primary care trust, and costs around £22,500 a year.
It offers ‘Love to Shop’ vouchers to girls aged 16 to 18 which can be spent at high street stores. They receive a total of £45 worth of vouchers for turning up for all three injections against the HPV virus.
The trust was advised by Mark Brighton, who used to work for Sainsbury’s Nectar card but has now set up a company called Healthy Incentives.
While the framed mainstream media debate is focused on whether the vaccine will encourage girls to be more promiscuous, the real debate should be whether the vaccine does what it claims and whether the vaccine is dangerous.
Although it is often called the Cervical Cancer vaccine, there is actually no such thing as a cervical cancer vaccine. It’s actually a vaccination against certain strains of the Human Papilloma Virus (HPV); which is being promoted as a cause of cervical cancer. Thus the logic is that preventing HPV will prevent cancer.
However the United States Food and Drug Administration (FDA), has quietly admitted that the majority of HPV cases have no direct link to cancer!
As reported by NaturalNews.com:
The FDA news release of March 31, 2003 acknowledges that “most infections (by HPV) are short-lived and not associated with cervical cancer”, in recognition of the advances in medical science and technology since 1988. In other words, since 2003 the scientific staff of the FDA no longer considers HPV infection to be a high-risk disease when writing educational materials for the general public whereas the regulatory arm of the agency is still bound by the old classification scheme that had placed HPV test as a test to stratify risk for cervical cancer in regulating the industry.
“Most women who become infected with HPV are able to eradicate the virus and suffer no apparent long-term consequences to their health.”
Furthermore Dr. Diane Harper, lead researcher in the development of two brands of HPV vaccine told the International Public Conference on Vaccination in October last year that 70 percent of all HPV infections resolve themselves without treatment within a year.  – if anyone should know it’s her.